Specifically, AQP4 loss is seen in astrocytes, and NMO has been proposed to be an immune astrocytopathy, driven mainly by antibodies against AQP4, and hence also referred to as an immune aquaporinopathy [9,10,11]. Here, AQP4 is linked to neuromyelitis optica.